Active	Status	Sponsor type	Region	Phase	Filter
1 Active 0 Inactive 1 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Amatruda, Thomas T
KEYNOTE-C86, NCT04993677 / 2021-002037-42: A Study of SEA-CD40 Given With Other Drugs in Cancers	Active, not recruiting	2	77	Europe, Canada, US	SEA-CD40, pembrolizumab, Keytruda, pemetrexed, Alimta, carboplatin, Paraplatin	Seagen Inc., Merck Sharp & Dohme LLC	Melanoma, Carcinoma, Non-Small- Cell Lung	01/24	10/25